Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 133 (Search time: 0.012 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2000Enhanced expression of osteocalcin mRNA in human osteoarthritic trabecular bone of the proximal femur is associated with decreased expression of interleukin-6 and interleukin-11 mRNAFindlay, D.; Atkins, G.; Forwood, M.; Kuliwaba, J.; Fazzalari, N.
2012Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesionGulati, K.; Ramakrishnan, S.; Aw, M.; Atkins, G.; Findlay, D.; Losic, D.
2011A preclinical study of stem subsidence and graft incorporation after femoral impaction grafting using porous hydroxyapatite as a bone graft extenderHowie, D.; Mc Gee, M.; Callary, S.; Carbone, A.; Stamenkov, R.; Bruce, W.; Findlay, D.
2004Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neckTsangari, H.; Findlay, D.; Kuliwaba, J.; Atkins, G.; Fazzalari, N.
2004Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NF[kappa]B, RANK ligand and osteoprotegerinCrotti, T.; Smith, M.; Findlay, D.; Zreiqat, H.; Ahern, M.; Weedon, H.; Hatzinikolous, G.; Capone, M.; Holding, C.; Haynes, D.
2013Collecting a comprehensive evidence base to monitor fracture rehabilitation: a case studyCallary, S.; Thewlis, D.; Rowlands, A.; Findlay, D.; Solomon, L.
2011TWEAK and TNF regulation of sclerostin: a novel pathway for the regulation of bone remodellingFindlay, D.; Atkins, G.
2011Relationship between serum RANKL and RANKL in boneFindlay, D.; Atkins, G.
2001The ratio of messenger RNA levels of receptor activator of nuclear factor kB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritisFazzalari, N.; Kuliwaba, J.; Atkins, G.; Forwood, M.; Findlay, D.
2002Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosisEvdokiou, A.; Bouralexis, S.; Atkins, G.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.